All companies
G

Glycyx

Develops cancer therapy designed to prevent opioids from reducing immunotherapy effectiveness.

Stage
Series A
Employees
3
Founded
2020
Category
Biotech & life sciences

Scores

Low search fit. Buyers of this kind of product rarely start with a search, so SEO matters less here.

Est. organic visits a month
20
Keywords ranking on Google
10
  • Strength32 / 100

    What the site earns from search today: estimated traffic, ranking keywords, content pages and technical basics.

  • Opportunity4 / 100

    Search demand the site is not capturing yet. It is high when demand is real, strength is low and the keywords are within reach.

  • Demand5 / 100

    How much people search for what this company sells, and how much traffic the top sites in its category earn.

  • Ease65 / 100

    How winnable the buyer keywords are.

  • Technical100 / 100

    Starts at 100 and drops for each problem found on the homepage, robots.txt and sitemap.

Get the report for Glycyx

The searches your customers make and the pages to build for them, written by OpenSEO from real SEO data.

Compared with peers

Glycyx is below the category median. The category is Biotech & life sciences, with 118 San Francisco startups on this list.

Estimated organic visits a month. Bars use a log scale.

Buyer keywords to target Suggestions

Searches a buyer of this product might type. They are generated from the company description, not taken from its analytics.

KeywordMonthly searchesDifficulty
cancer immunotherapy research14039 / 100
how to manage cancer pain1032 / 100
opioids and immunotherapyToo low to measure–
cancer pain treatment researchToo low to measure–
anti pd1 therapy researchToo low to measure–
how opioids affect immunotherapyToo low to measure–

Monthly searches are US Google averages. Difficulty runs from 0 (easy to rank) to 100 (very hard).

What the site has today

Pages in sitemap
19
Built with
Wix
llms.txt
Yes
Title
Glycyx | Restoring immune function in immuno-oncology
Meta description
Glycyx is at the forefront of cancer treatment by addressing the overlooked issue of opioids reducing immunotherapy effectiveness. As a biotech firm entering Phase 2, we are pioneering a novel therapy to ensure pain management doesn
H1
What we do

Page types in the sitemap

Not found: docs, comparison pages, integration pages, customer stories, use case pages, glossary pages, templates, changelog, product pages, jobs and careers pages.

Fixes

No problems found on the homepage, robots.txt or sitemap.

Share this page

Audit every page with OpenSEO

This page covers the homepage, robots.txt and sitemap. OpenSEO also tracks your rankings and shows where competitors get their traffic.

Site checked Nov 18, 2026. Traffic is a modeled estimate and company data can be wrong. Ask for a correction or removal · Methodology